Table 1. Pre-treatment Characteristics by Genotype.
| Genotype | RR | RQ | ||||
|---|---|---|---|---|---|---|
| N | (%) | N | (%) | N | (%) | |
|
| ||||||
| 104 | (44.8) | 101 | (43.5) | 27 | (11.6) | |
| Race | ||||||
| Caucasian | 86 | (82.7) | 97 | (96.1) | 27 | (100) |
| African American | 12 | (11.5) | 0 | (0) | 0 | (0) |
| Other | 6 | (5.8) | 4 | (.9) | 0 | (0) |
| *OR (95% CI) | 1.0 (ref. group) | 5.08 (1.65-15.58) | N/A | |||
|
| ||||||
| Positive Family History** | 25 | (24.0) | 22 | (21.8) | 6 | (22.2) |
| OR (95% CI) | 1.0 (ref. group) | 0.88 (0.46-1.69) | 0.90 (0.33-2.49) | |||
|
| ||||||
| Age at disease onset† | ||||||
| Median | 58 years 11 months | 59 years 4 months | 58 years 0 months | |||
| Range | (43y6m-73y2m) | (43y7m-73y1m) | (38y7m-69y4m) | |||
*
OR = likelihood Caucasian
**
p = 0.9, chi-square
†
p = 0.6, log rank